This study shows first evidence on the role of glucose transporter SGLT2 in CRC cells, as demonstrated by the cytotoxic effect of iSGLT2, canagliflozin, via impaired glucose metabolism and mitochondrial bioenergetic injury. Here, SLC5A2 is linked to colorectal carcinoma.